Delivery Order SPE2DB22D3019-SPE2DB23FK3HL

Award Date 3/20/23
Potential Completion Date 3/21/23
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Xarelto 15 mg tablets, a medication used for cardiovascular health, and has a ceiling value of $7,124.49. The contract has an ultimate completion date of December 12, 2024. This award is a firm fixed-price contract and is not designated as a set-aside. Amerisourcebergen maintains a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 15 mg tablets. The contract has a ceiling value of $1,630.96 and a completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Xarelto 20 mg tablets, a cardiovascular medication, valued at $3,868.14. The contract has a completion date of September 26, 2024 and is a firm fixed-price, delivery order type contract. This award is a part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Xarelto 20mg tablets, a medication used for cardiovascular health, for a total ceiling value of $5,344.01. The contract has an ultimate completion date of October 26, 2023 and is a firm fixed-price delivery order contract. This award is part of a larger Indefinite Delivery Contract (IDC) vehicle held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4557840901 Xarelto 15 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $1,496.59 and a period of performance ending on July 20, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Xarelto 10 mg tablets, a cardiovascular medication, to support military healthcare programs. The Delivery Order has a ceiling value of $5,154.91 and a period of performance through April 2025. The parent IDC with DLA Troop Support Medical is valued at $999,999,999 and runs...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $15,354.89 firm fixed price contract is for the delivery of Xarelto 15mg tablets. The award has an ultimate completion date of August 29, 2024 and was made on August 28, 2024. This order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Xarelto 20 mg tablets, a cardiovascular medication, with a ceiling value of $6,334.96 and an ultimate completion date of April 3, 2023. The contract is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xarelto 20 mg tablets, a cardiovascular medication, with a ceiling value of $18,064.38 and a completion date of January 28, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,006.15 firm fixed-price contract is for the delivery of Xarelto 15 mg tablets, a prescription medication for cardiovascular health conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
  • SPE2DB22D3019
    Indefinite Delivery Contract
  • SPE2DB22D3019-SPE2DB23FK3HL
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Xarelto 15 mg tablets, a medication used for cardiovascular health. The award is valued at $12,837.92 and has a period of performance through March 21, 2023. This appears to be an order against a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular award was not designated as a set-aside contract.

Generated 4/11/25, 11:24 AM